Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Neil Wenger, M.D., M.P.H.
Neil Wenger, M.D., M.P.H.

Specialty:

Internal Medicine

General Information:

Gender:
Male
Language(s):
English, Spanish

Affiliation(s):

Professor, Department of Medicine, General Internal Medicine
Director, UCLA Healthcare Ethics Center
Chair, Ethics Committee, Ronald Reagan UCLA Medical Center
Member, JCCC Patients and Survivors Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center

Education:

Fellowship:
Internal Medicine, UCLA School of Medicine, 1987 - 1989
Residency:
Internal Medicine, UCLA School of Medicine, 1985 - 1987
Internship:
Internal Medicine, UCLA School of Medicine, 1984 - 1985
Medical Degree:
M.D., UCLA School of Medicine, 1984

Certification(s):

Medical Board Certification(s):
Internal Medicine, American Board of Internal Medicine, 1987

Contact Information:

Phone:
(310) 794-2288
Email:

Practice Information:

Clinical Interest(s):
AIDS

Scientific Interest(s):

Dr. Neil Wenger's primary interests are measuring quality of care for older patients, advance care planning and care decisions toward the end of life, and the relationship and communication between a physician and patient.

Selected Cancer-Related Publications:

Quality Indicators for Continuity and Coordination of Care in Vulnerable Elders. Quality Indicators for Continuity and Coordination of Care in Vulnerable Elders. J Am Geriatr Soc. 2007 Oct;55 Suppl 2:S285-92.

Wenger NS, Solomon DH, Roth CP, MacLean CH, Saliba D, Kamberg CJ, Rubenstein LZ, Young RT, Sloss EM, Louie R, Adams J, Chang JT, Venus PJ, Schnelle JF, Shekelle PG. The quality of medical care provided to vulnerable community-dwelling older patients. Ann Intern Med. 2003 Nov 4;139(9):740-7.

Wenger NS, Kanouse DE, Collins RL, Liu H, Schuster MA, Gifford AL, Bozzette SA, Shapiro MF. End-of-life discussions and preferences among persons with HIV. JAMA. 2001 Jun 13;285(22):2880-7.

Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, Shekelle PG. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA. 2000 Dec 6;284(21):2755-61.

Weeks JC, Cook EF, O'Day SJ, Peterson LM, Wenger N, Reding D, Harrell FE, Kussin P, Dawson NV, Connors AF Jr, Lynn J, Phillips RS. Relationship Between Cancer Patients’ Predictions of Prognosis and Their Treatment Preferences. JAMA. 1998 Jun 3;279(21):1709-14.